Dermata Therapeutics, Inc.
DRMA
$6.45
$0.2183.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 105.32% | -57.49% | -7.35% | -41.37% | -46.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -19.68% | -19.94% | -14.62% | -29.79% | -21.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -97.85% | -86.18% | -76.38% | 116.34% | 24.20% |
| Total Current Assets | 93.15% | -55.71% | -8.69% | -39.90% | -44.27% |
|
|
|||||
| Total Current Assets | 93.15% | -55.71% | -8.69% | -39.90% | -44.27% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 93.15% | -55.71% | -8.69% | -39.90% | -44.27% |
|
|
|||||
| Total Accounts Payable | 69.64% | -6.70% | 82.00% | 203.15% | 66.87% |
| Total Accrued Expenses | 138.26% | 53.75% | 144.69% | 141.21% | -23.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 97.10% | 21.51% | 112.27% | 180.92% | 13.65% |
|
|
|||||
| Total Current Liabilities | 97.10% | 21.51% | 112.27% | 180.92% | 13.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 97.10% | 21.51% | 112.27% | 180.92% | 13.65% |
|
|
|||||
| Common Stock & APIC | 24.78% | 12.54% | 16.66% | 8.87% | 7.88% |
| Retained Earnings | -20.27% | -23.02% | -21.99% | -19.82% | -18.16% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 91.73% | -75.44% | -26.00% | -58.68% | -52.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 91.73% | -75.44% | -26.00% | -58.68% | -52.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 91.73% | -75.44% | -26.00% | -58.68% | -52.92% |
|
|
|||||